119 related articles for article (PubMed ID: 37871610)
1. Untargeted metabolomic profiles reveal widespread metabolic perturbations and identify candidate biomarkers in aminoaciduric canine hypoaminoacidemic hepatopathy syndrome.
Loftus JP; Rubio MED; Yant J; Bichoupan A; Zhang S; Miller AJ; Center SA; Ruiz MDR; Macho LP
Am J Vet Res; 2023 Dec; 84(12):. PubMed ID: 37871610
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and amino acid profiles of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy.
Loftus JP; Center SA; Astor M; Miller AJ; Peters-Kennedy J
J Vet Intern Med; 2022 Jan; 36(1):97-105. PubMed ID: 34477245
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of glucagon and glucagon-like peptide-1 are reduced in dogs with aminoaciduric canine hypoaminoacidemic hepatopathy syndrome versus healthy dogs: a preliminary study.
Holm SM; Peng SA; Holter MM; Cummings BP; Loftus JP
Am J Vet Res; 2023 Apr; 84(4):. PubMed ID: 36773290
[TBL] [Abstract][Full Text] [Related]
4. Treatment and outcomes of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy.
Loftus JP; Miller AJ; Center SA; Peters-Kennedy J; Astor M
J Vet Intern Med; 2022 Jan; 36(1):106-115. PubMed ID: 34820906
[TBL] [Abstract][Full Text] [Related]
5. Targeted metabolomic analysis identifies increased serum levels of GABA and branched chain amino acids in canine diabetes.
O'Kell AL; Wasserfall C; Guingab-Cagmat J; Webb-Roberston BM; Atkinson MA; Garrett TJ
Metabolomics; 2021 Nov; 17(11):100. PubMed ID: 34775536
[TBL] [Abstract][Full Text] [Related]
6. Untargeted metabolomic analysis in naturally occurring canine diabetes mellitus identifies similarities to human Type 1 Diabetes.
O'Kell AL; Garrett TJ; Wasserfall C; Atkinson MA
Sci Rep; 2017 Aug; 7(1):9467. PubMed ID: 28842637
[TBL] [Abstract][Full Text] [Related]
7. Plasma-free amino acid profiles in dogs with hepatocellular carcinoma.
Leela-Arporn R; Ohta H; Tamura M; Nagata N; Sasaoka K; Dermlim A; Nisa K; Osuga T; Morishita K; Sasaki N; Takiguchi M
J Vet Intern Med; 2019 Jul; 33(4):1653-1659. PubMed ID: 31066966
[TBL] [Abstract][Full Text] [Related]
8. Identifying potential biomarkers and therapeutic targets for dogs with sepsis using metabolomics and lipidomics analyses.
Montague B; Summers A; Bhawal R; Anderson ET; Kraus-Malett S; Zhang S; Goggs R
PLoS One; 2022; 17(7):e0271137. PubMed ID: 35802586
[TBL] [Abstract][Full Text] [Related]
9. Identification of canine mammary tumor-associated metabolites using untargeted metabolomics.
Yu C; Zheng HH; Zhang YZ; Du CT; Xie GH
Theriogenology; 2023 Nov; 211():84-96. PubMed ID: 37603937
[TBL] [Abstract][Full Text] [Related]
10. Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic disease.
Lawrence YA; Guard BC; Steiner JM; Suchodolski JS; Lidbury JA
PLoS One; 2019; 14(5):e0217797. PubMed ID: 31150490
[TBL] [Abstract][Full Text] [Related]
11. Identification of Canine Pyometra-Associated Metabolites Using Untargeted Metabolomics.
Zheng HH; Du CT; Zhang YZ; Yu C; Huang RL; Tang XY; Xie GH
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430638
[TBL] [Abstract][Full Text] [Related]
12. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic serum abnormalities in dogs with hepatopathies.
Imbery CA; Dieterle F; Ottka C; Weber C; Schlotterbeck G; Müller E; Lohi H; Giger U
Sci Rep; 2022 Mar; 12(1):5329. PubMed ID: 35351920
[TBL] [Abstract][Full Text] [Related]
14. Profound Perturbation in the Metabolome of a Canine Obesity and Metabolic Disorder Model.
Qu W; Chen Z; Hu X; Zou T; Huang Y; Zhang Y; Hu Y; Tian S; Wan J; Liao R; Bai L; Xue J; Ding Y; Hu M; Zhang XJ; Zhang X; Zhao J; Cheng X; She ZG; Li H
Front Endocrinol (Lausanne); 2022; 13():849060. PubMed ID: 35620391
[TBL] [Abstract][Full Text] [Related]
15. Metabolome of canine and human saliva: a non-targeted metabolomics study.
Turunen S; Puurunen J; Auriola S; Kullaa AM; Kärkkäinen O; Lohi H; Hanhineva K
Metabolomics; 2020 Aug; 16(9):90. PubMed ID: 32840693
[TBL] [Abstract][Full Text] [Related]
16. Characterization of aminoaciduria and hypoaminoacidemia in dogs with hepatocutaneous syndrome.
Loftus JP; Center SA; Lucy JM; Stanton JA; McDonough SP; Peters-Kennedy J; Arceneaux KA; Bechtold MA; Bennett CL; Bradbury CA; Cline MG; Hall-Fonte DL; Hammer-Landrum JF; Huntingford JL; Marshall J; Sharpe KS; Redin JL; Selva ST; Lucia TA
Am J Vet Res; 2017 Jun; 78(6):735-744. PubMed ID: 28541155
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic profiling to identify early urinary biomarkers and metabolic pathway alterations in autosomal dominant polycystic kidney disease.
Houske EA; Glimm MG; Bergstrom AR; Slipher SK; Welhaven HD; Greenwood MC; Linse GM; June RK; Yu ASL; Wallace DP; Hahn AK
Am J Physiol Renal Physiol; 2023 Jun; 324(6):F590-F602. PubMed ID: 37141147
[TBL] [Abstract][Full Text] [Related]
18. Short-term parenteral infusions with high-osmolality amino acid solutions can be safely administered through peripheral catheters in dogs treated for hypoaminoacidmia-related conditions.
Arsenault AC; Loftus JP; Rishniw M
J Am Vet Med Assoc; 2024 Feb; ():1-6. PubMed ID: 38354472
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics Analysis Reveals Deranged Energy Metabolism and Amino Acid Metabolic Reprogramming in Dogs With Myxomatous Mitral Valve Disease.
Li Q; Larouche-Lebel É; Loughran KA; Huh TP; Suchodolski JS; Oyama MA
J Am Heart Assoc; 2021 May; 10(9):e018923. PubMed ID: 33890477
[TBL] [Abstract][Full Text] [Related]
20. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway.
Shayota BJ; Donti TR; Xiao J; Gijavanekar C; Kennedy AD; Hubert L; Rodan L; Vanderpluym C; Nowak C; Bjornsson HT; Ganetzky R; Berry GT; Pappan KL; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2020; 131(1-2):147-154. PubMed ID: 32828637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
